Albemarle Corporation (ALB) earnings on August 5, 2026
More Albemarle Corporation earnings
Prior outlook: Pessimistic Outcome: Missed
The stock rose 5.2% after the company's quarterly results beat expectations, even though future sales outlook was weaker than hoped.
ALB price around the earnings
125.42
Change: +5.1%
2026-08-06, 20:00 UTC
Start of the measured window
End of the measured window
118.00
121.93
125.85
129.78
119.33
August 5, 2026
August 6, 2026
- Price: green if it ends above the starting price; red if it ends below
- Start of the measured window
- End of the measured window
- Market open
- No trading (market closed)
- Starting price
Prior thesis
Prior outlook: Pessimistic Outcome: Missed
- Thesis published
- Results released
Despite strong historical beats, recent analyst price target cuts and a collapsing trajectory context execution risk.
Context analyzed before publication
- Trend
- Deeply after a strong recent drop, but trajectory collapsed significantly in recent days, signaling strong selling pressure into earnings.
Analysts
Evidence
- Analyst consensus
- Buy
- Consensus average (1-5)
- 1.95
- Analysts covering the stock
- 20
- Average price target
- 187.16
- Lowest price target
- 83.28
- Highest price target
- 250
- Upside to price target
- 57.1%
- Quarterly earnings growth
- 671.7%
- Revenue growth
- 32.7%
- Forward EPS
- 12.47
- Trailing EPS
- -3.42
- Analyst moves in the last 60 days
- 4
- July 28, 2026 · Scotiabank: Maintains rating (Sector Outperform → Sector Outperform)
- July 20, 2026 · Truist Securities: Maintains rating (Buy → Buy)
- July 1, 2026 · Mizuho: Maintains rating (Neutral → Neutral)
- June 18, 2026 · Citigroup: Upgrades rating (Neutral → Buy)
News and sentiment
Evidence
Sentiment
- Sentiment
- Constructive
- Mention volume
- High
- Normalized volume
- 99%
News
Sources (3)
- Scotiabank Maintains Sector Outperform on Albemarle, Lowers Price Target to $200 (opens in a new tab) — Benzinga
- Top 3 Materials stocks That Could Lead To Your Biggest Gains In Q3 (opens in a new tab) — Benzinga
- Truist Securities Maintains Buy on Albemarle, Lowers Price Target to $245 (opens in a new tab) — Benzinga
Technicals
Evidence
- Price when the context was analyzed
- 120.81
- Average true range (ATR)
- 3.4%
- Distance to 52-week high
- -44.6%
- 14-day change (14d)
- +1.9%
- 30-day change (33d)
- -10.9%
- 30-day relative strength
- -14.4%
- SPY change (33d)
- +3.5%
- Nearest support
- 120.08
- Distance to nearest support
- 0.6%
- Nearest resistance
- 121.56
- Distance to nearest resistance
- 0.6%
- Volume accumulation ratio (14d / 46d)
- 0.88
- Mid: 120.08 (0.6% away, 0.17 ATR, 12 touches)
- Mid: 119.26 (1.3% away, 0.37 ATR, 20 touches)
- Mid: 118.26 (2.1% away, 0.61 ATR, 16 touches)
- Mid: 121.56 (0.6% away, 0.18 ATR, 4 touches)
- Minor: 122.5 (1.4% away, 0.41 ATR, 6 touches)
- Mid: 124.71 (3.2% away, 0.94 ATR, 18 touches)
Trends
Evidence
- Average earnings surprise
- +77.0%
- May 6, 2026: actual EPS 2.95 vs estimate 1.31 (surprise +124.6%)
- February 11, 2026: actual EPS -0.53 vs estimate -0.49 (surprise -8.6%)
- November 5, 2025: actual EPS -0.19 vs estimate -0.88 (surprise +78.3%)
- July 30, 2025: actual EPS 0.11 vs estimate -0.81 (surprise +113.5%)
Expected move
- Implied move
- +6.0%
- Source
- Options chain
Reactions over its last 20 earnings
- Median move
- 3%
- 75th percentile move
- 4.9%
- 90th percentile move
- 9.4%
- Up / down moves
- 13 / 7
- Average up move
- +3.8%
- Average down move
- -5.1%
Monitoring and close
What Albemarle Corporation reported
- Status
- Finished
| Actual EPS | 3.75 |
|---|---|
| EPS estimate | 3.24 |
| EPS surprise | +15.7% |
| Revenue | $1,743 million |
| Revenue estimate | $1,603 million |
| Revenue surprise | +8.7% |
Albemarle beat Q2 expectations: adjusted earnings of $3.75 per share and revenue of $1.743 billion, both above estimates.
Sources (2)
- Albemarle beat expectations in Q2: adjusted earnings of $3.75 per share versus $3.24 estimated, and revenue of $1.743 billion versus $1.603 billion. — Benzinga
- Albemarle Q2 Adj. EPS $3.75 Beats $3.24 Estimate, Sales $1.743B Beat $1.603B Estimate (opens in a new tab) — Benzinga
Pre-market second reading after the results
- Verdict
- Beat expectations
Heading into the open, results beat expectations on both earnings and revenue, and the price is indicating +4.7% pre-market, a move above the stock's usual reaction (about 3%). The figures don't confirm the prior scenario: the comparable cases aren't consistent enough.
How the stock reacted
- Outcome
- Missed
- Consolidated
- +5.2%
- Max favorable move (MFE)
- 1.1%
- Max adverse move (MAE)
- 8.9%